Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Different Sensitivity of Macrophages to Phospholipidosis Induction by Amphiphilic Cationic Drugs.

Tytuł:
Different Sensitivity of Macrophages to Phospholipidosis Induction by Amphiphilic Cationic Drugs.
Autorzy:
Öhlinger K; Center for Medical Research, Medical University of Graz, Stiftingtalstr. 24, 8010 Graz, Austria.
Absenger-Novak M; Center for Medical Research, Medical University of Graz, Stiftingtalstr. 24, 8010 Graz, Austria.
Meindl C; Center for Medical Research, Medical University of Graz, Stiftingtalstr. 24, 8010 Graz, Austria.
Ober J; Center for Medical Research, Medical University of Graz, Stiftingtalstr. 24, 8010 Graz, Austria.
Fröhlich E; Center for Medical Research, Medical University of Graz, Stiftingtalstr. 24, 8010 Graz, Austria.; Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, 8010 Graz, Austria.
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2020 Nov 09; Vol. 21 (21). Date of Electronic Publication: 2020 Nov 09.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: Basel, Switzerland : MDPI, [2000-
MeSH Terms:
Amiodarone/*adverse effects
Cations/*adverse effects
Chloroquine/*adverse effects
Lysosomal Storage Diseases/*chemically induced
Macrophages/*drug effects
Macrophages/*metabolism
Phospholipids/*metabolism
Animals ; Cell Line ; Humans ; Lysosomal Storage Diseases/metabolism ; Mice ; Monocytes/drug effects ; RAW 264.7 Cells ; THP-1 Cells
References:
Environ Health Perspect. 1976 Aug;16:111-8. (PMID: 189997)
Pharmaceutics. 2019 Jul 17;11(7):. (PMID: 31319538)
Cell Biol Toxicol. 2006 Jan;22(1):15-27. (PMID: 16463016)
Cell Prolif. 2013 Jun;46(3):328-47. (PMID: 23692091)
Can Respir J. 2009 Mar-Apr;16(2):43-8. (PMID: 19399307)
Inflamm Res. 2007 Jan;56(1):45-50. (PMID: 17334670)
Pharmacol Rev. 1990 Dec;42(4):327-54. (PMID: 2080227)
J Biomol Screen. 2010 Apr;15(4):398-405. (PMID: 20237207)
Int J Mol Sci. 2018 Mar 17;19(3):. (PMID: 29562615)
Theranostics. 2019 Oct 15;9(25):7714-7729. (PMID: 31695796)
Sci Rep. 2015 Nov 18;5:16632. (PMID: 26577684)
Cell Biol Toxicol. 2003 Jun;19(3):161-76. (PMID: 12945744)
Exp Mol Pathol. 2001 Apr;70(2):77-82. (PMID: 11263950)
Turk J Emerg Med. 2018 Aug 07;18(3):91-93. (PMID: 30191186)
ERJ Open Res. 2017 Mar 20;3(1):. (PMID: 28344981)
PLoS One. 2018 Mar 14;13(3):e0193601. (PMID: 29538403)
Anal Biochem. 2001 Jul 15;294(2):118-25. (PMID: 11444806)
Respir Res. 2018 Apr 18;19(1):66. (PMID: 29669565)
Front Immunol. 2015 Jun 25;6:330. (PMID: 26124761)
Nat Commun. 2018 Feb 28;9(1):873. (PMID: 29491374)
Cell Death Dis. 2017 Aug 24;8(8):e3014. (PMID: 28837152)
J Leukoc Biol. 1997 Apr;61(4):469-80. (PMID: 9103234)
J Toxicol. 2012;2012:308594. (PMID: 22745636)
Pharm Res. 2017 Dec;34(12):2466-2476. (PMID: 28540501)
Mol Cell Biochem. 1987 Aug;76(2):163-72. (PMID: 2823097)
Anticancer Res. 2011 Jul;31(7):2467-76. (PMID: 21873161)
Immunity. 2006 Apr;24(4):366-8. (PMID: 16618595)
PLoS One. 2018 Oct 10;13(10):e0205520. (PMID: 30304023)
J Vis Exp. 2016 Jun 30;(112):. (PMID: 27404952)
Toxicol Pathol. 1997 Jan-Feb;25(1):53-60. (PMID: 9061852)
Lung. 1994;172(2):91-102. (PMID: 7509428)
FEBS Lett. 2006 Oct 9;580(23):5533-40. (PMID: 16979167)
Acta Clin Belg. 1995;50(5):260-8. (PMID: 8533525)
Food Funct. 2013 Feb;4(2):266-76. (PMID: 23135314)
PLoS One. 2017 Apr 26;12(4):e0176460. (PMID: 28445506)
PLoS One. 2018 Jun 11;13(6):e0198943. (PMID: 29889899)
Cytometry A. 2010 Mar;77(3):231-42. (PMID: 20014301)
J Cell Sci. 2016 Dec 15;129(24):4622-4632. (PMID: 27875278)
Biotech Histochem. 2017;92(7):467-480. (PMID: 28836856)
J Immunol. 2003 Jul 15;171(2):669-77. (PMID: 12847232)
Oncotarget. 2017 Jul 18;8(47):82326-82343. (PMID: 29137267)
Front Immunol. 2016 Dec 26;7:649. (PMID: 28082984)
Pharmaceutics. 2020 Mar 13;12(3):. (PMID: 32183061)
Eur Respir J. 2010 May;35(5):1039-47. (PMID: 19897561)
Open Respir Med J. 2012;6:63-74. (PMID: 22896776)
Contributed Indexing:
Keywords: cationic amphiphilic drugs; drug screening; high-content screening; inhalation; inter-species differences; macrophages; phospholipidosis; toxicity
Substance Nomenclature:
0 (Cations)
0 (Phospholipids)
886U3H6UFF (Chloroquine)
N3RQ532IUT (Amiodarone)
Entry Date(s):
Date Created: 20201113 Date Completed: 20210302 Latest Revision: 20210302
Update Code:
20240105
PubMed Central ID:
PMC7664898
DOI:
10.3390/ijms21218391
PMID:
33182310
Czasopismo naukowe
Phospholipidosis (PLD), the intracellular accumulation of phospholipids, is an adaptive response to toxic stimuli and serves as an important parameter in the biological assessment of compounds. Cationic amphiphilic drugs are the main inducers of PLD and may impair the function of alveolar macrophages. In vivo and in vitro models are used for PLD screening but the choice of the cellular model may be important because PLD develops in a cell- and species-specific manner. In this study, a panel of different staining (LysoSensor, Acridine Orange, Nile Red, HCS LipidTOX, LysoID) was evaluated in murine (DMBM-2, J774, RAW264.7) and human (THP-1, monocyte-derived macrophages from peripheral blood) cells to identify the most sensitive and easy to analyze staining method and to detect species-specific differences in the reaction pattern. Amiodarone and chloroquine served as inducers of PLD. High content screening was used to compare number, area, and intensity of the staining. Due to the fast staining protocol and the sensitivity of the detection, LysoID proved to be the most suitable dye of the testing. The lower induction of PLD by chloroquine reported in vivo was also seen in this study. THP-1 macrophages, followed by DMBM-2 cells, produced the most similar reaction pattern to human monocyte-derived macrophages.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies